80 related articles for article (PubMed ID: 7410831)
1. Effect of reduction on the structural, biologic, and immunologic properties of the third component of human complement.
Zemel ES; Cartwright-Harwick CM; Nilsson UR
J Immunol; 1980 Sep; 125(3):1099-103. PubMed ID: 7410831
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
3. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of Guinea pig properidin.
Nicholson A; Austen KF
J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
[TBL] [Abstract][Full Text] [Related]
5. Identity of C3- and C5-receptors on lymphoid cells.
Landen B; Dierich MP
J Immunol; 1979 Mar; 122(3):1015-7. PubMed ID: 448068
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of specific binding activity of guinea pig complement C3 by dithiothreitol].
Takahashi S; Tanaka K; Kono H; Takahashi M
Arerugi; 1972 Jan; 21(1):40-9. PubMed ID: 4623566
[No Abstract] [Full Text] [Related]
7. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of formation of complement C5-convertase].
Kozlov LV; Lebedeva TV
Bioorg Khim; 1998 May; 24(5):350-5. PubMed ID: 9661788
[TBL] [Abstract][Full Text] [Related]
9. Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies.
Burger R; Deubel U; Hadding U; Bitter-Suermann D
J Immunol; 1982 Nov; 129(5):2042-50. PubMed ID: 6181157
[No Abstract] [Full Text] [Related]
10. A hemolytic method for the measurement of nephritic factor.
West CD
J Immunol Methods; 2008 Jun; 335(1-2):1-7. PubMed ID: 18410942
[TBL] [Abstract][Full Text] [Related]
11. Active-site disruption in native Limulus hemocyanin and its subunits by disulfide-bond reductants: a chemical probe for the study of structure-function relationships in the hemocyanins.
Topham R; Tesh S; Cole G; Mercatante D; Westcott A; Bonaventura C
Arch Biochem Biophys; 1998 Apr; 352(1):103-13. PubMed ID: 9521822
[TBL] [Abstract][Full Text] [Related]
12. Cell-bound C4b resists reduction by reducing agents: analysis by chain structure and by hemolytic activity.
Ejzemberg R; Brown EJ; Ohanian SH; Hammer CH; Borsos T
J Immunol; 1983 Jun; 130(6):2825-30. PubMed ID: 6602183
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of the third component of complement in the serum of the clawed frog, Xenopus laevis.
Sekizawa A; Fujii T; Katagiri C
J Immunol; 1984 Sep; 133(3):1436-43. PubMed ID: 6747292
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
15. Evidence that bovine conglutinin reacts with an early product of C3b degradation, and an improved conglutination assay.
Linscott WD; Ranken R; Triglia RP
J Immunol; 1978 Aug; 121(2):658-64. PubMed ID: 98586
[TBL] [Abstract][Full Text] [Related]
16. Third component of trout complement. cDNA cloning and conservation of functional sites.
Lambris JD; Lao Z; Pang J; Alsenz J
J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
[TBL] [Abstract][Full Text] [Related]
17. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
18. Study on C3-like factor in the serum of a C3-deficient subject.
Kitamura H; Nishimukai H; Sano Y; Nagaki K
Immunology; 1984 Feb; 51(2):239-45. PubMed ID: 6693133
[TBL] [Abstract][Full Text] [Related]
19. The many effects of complement C3- and C5-binding proteins in renal injury.
Puri TS; Quigg RJ
Semin Nephrol; 2007 May; 27(3):321-37. PubMed ID: 17533009
[TBL] [Abstract][Full Text] [Related]
20. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
Rawal N; Pangburn MK
Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
